This site uses cookies. By continuing to use this site you agree to our use of cookies. Learn more about our cookie policy.Close

Activities

Public Statements Downloads

January 06, 2016

IPPC Comments to HHS re Common Rule NPRM

pdf

December 14, 2015

IPPC Letter to European Data Protection Supervisor re EMA Anonymisation Guidance for Clinical Study Reports

pdf

June 17, 2015

IPPC-EFPIA-ACRO Joint Comments on Draft WMA Declaration on Ethical Considerations regarding Health Databases and Biobanks

pdf

November 07, 2014

IPPC Comments to U.S. House Energy and Commerce Committee on "21st Century Cures"

pdf

October 13, 2014

IPPC White Paper on Anonymisation of Clinical Trial Data Sets

pdf

August 15, 2014

Joint IPPC and I-PWG Comments to the working document on research on biological materials of human origin

pdf

August 11, 2014

Joint IPPC and MDPC Comments to US Federal Communications Commission (FCC) on CG Docket No. 05-338

pdf

July 03, 2014

IPPC Comments to European Commission on mHealth Consultation Paper

pdf

June 09, 2014

IPPC Comments to Federal Trade Commission (FTC) on Consumer Generated and Controlled Health Data

pdf

March 06, 2012

IPPC Comments to UK Ministry of Justice in Response to Call for Evidence on European Commission Proposed Data Protection Regulation

pdf

October 26, 2011

IPPC Comments to US Department of Health and Human Services on the Advanced Notice of Proposed Rulemaking Concerning Human Subject Research Protections (the "Common Rule")

pdf

August 03, 2011

IPPC Comments on Draft Data Privacy Regulations in Mexico

pdf

February 28, 2011

IPPC Comments to Indian Ministry of Communications and Information Technology on the Draft Rules Under Section 43A of the IT Act Concerning Reasonable Security Practices and Procedures and Sensitive Personal Information

pdf

February 18, 2011

IPPC comments to US Federal Trade Commission on "Protecting Consumer Privacy in an Era of Rapid Change: A Proposed Framework for Businesses and Policymakers"

pdf

January 28, 2011

IPPC comments to US Department of Commerce on "Data Privacy and Innovation in the Internet Economy: A Dynamic Policy Framework"

pdf

January 14, 2011

IPPC Comments to the European Commission in Response to Its Consultation on Personal Data Protection in the EU

pdf

September 13, 2010

IPPC Comments to HHS on Proposed Rule Under the HITECH Act Modifying the HIPAA Privacy, Security & Enforcement Rules

pdf

July 01, 2010

Comments submitted jointly with the Association of Clinical Research Organizations (ACRO) in response to the European Commission Stakeholders' Consultations "Future of Data Protection" Background Paper

pdf

June 14, 2010

IPPC Comments to US Department of Commerce on US Privacy Framework

pdf

June 04, 2010

IPPC Comments on US Reps Boucher and Stearns Proposed Privacy Legislation

pdf

April 14, 2010

IPPC Comments to the US Federal Trade Commission in Relation to the Exploring Privacy Roundtable Series

pdf

April 06, 2010

Working Document on the Collection, Processing, and Transfer of Biomedical Research and Pharmacovigilance Data

pdf

April 06, 2010

Working Document on the Collection, Processing, and Transfer of Biomedical Research and Pharmacovigilance Data - Spanish

pdf

December 23, 2009

IPPC Comments to the European Commission in Response to Its Consultation on the Legal Regime for Data Privacy in the EU

pdf

September 01, 2009

White Paper: Understanding Safety Surveillance

pdf

September 01, 2009

White Paper: Understanding the Clinical Research Process

pdf

March 01, 2008

IPPC Comments to IOM Committee on Health Research and Privacy

pdf

March 01, 2008

Privacy FAQs for Marketing to U.S. Consumers

pdf

March 01, 2008

IPPC Voluntary Set of Privacy Guidelines for Marketing to U.S. Consumers

pdf

February 01, 2008

IPPC Comments on the EU Article 29 Working Party Opinion on the Concept of 'Personal Data'

pdf

August 01, 2006

IPPC White Paper on the Transmission Security Practices of Pharmaceutical Sponsors of Clinical Research Studies

pdf

June 27, 2005

IPPC Comments to US Federal Trade Commission on Notice of Proposed Rulemaking re: Definitions, Implementation, and Reporting Requirements Under the CAN-SPAM Act

pdf

April 20, 2004

IPPC Comments to US Federal Trade Commission on Advance Notice of Proposed Rulemaking re: Definitions, Implementation, and Reporting Requirements Under the CAN-SPAM Act

pdf

April 01, 2003

White Paper: HIPAA and Routine Interactions Between Physicians and Pharmaceutical Sales Representatives

pdf

April 01, 2003

White Paper: Pharmaceutical Companies are not Business Associates when Acting as Sponsors of Clinical Research

pdf

Over the last century, medical science has transformed human health and dramatically increased life expectancy. The life saving treatments available today were made possible by an environment that fostered medical research. The scientific process used in medical research relies on the ability to effectively collect, analyze and reanalyze patient health information. Pharmaceutical companies collect patient health information created in controlled research settings (e.g., clinical trials to investigate an experimental drug), as well as real world patient health data.

↑ Top

© 2017 INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM
Privacy Policy Cookie Policy Terms & Conditions

Designed and Developed by Reef Light Interactive